DHR

Equity

Danaher Corporation

Health Care · Diagnostics & Research

$204.92

+204.92 (+0.00%)

Open

N/A

Day Range

$203.27 - $205.15

52W Range

$171.00 - $242.80

Volume

197K

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Latest News

Pall Corporation Appoints Dr. Roland Folz as President

PR Newswire 1 day ago

Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness

Simply Wall St. 4 days ago

Danaher (DHR) Down 4.7% Since Last Earnings Report: Can It Rebound?

Zacks 4 days ago

Where is Danaher Corporation (DHR) Headed?

Insider Monkey 5 days ago

Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer

PR Newswire 6 days ago

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ABBV AbbVie Inc. $233.86 N/A 2.84% +0.00%
ACB Aurora Cannabis Inc. $3.71 N/A - +0.00%
AKBA Akebia Therapeutics, Inc. $1.26 N/A - +0.00%
ABCL AbCellera Biologics Inc. $3.74 N/A - +0.00%
ACAD ACADIA Pharmaceuticals Inc. $22.81 N/A - +0.00%
001540.KQ AHN-GOOK PHA $7,870.00 N/A 5.59% +0.00%
A Agilent Technologies, Inc. $116.88 N/A 0.85% +0.00%
ABT Abbott Laboratories $114.12 N/A 2.10% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

www.danaher.com →

🐂 Bull Score

Our proprietary rating measures dividend reliability based on 6 fundamental factors including payout sustainability, financial strength, and cash flow coverage.

F 21/100

Very Risky

Bull Score

~ Growing dividend (8 years) 10/25
+ Good profit margin (15%) 11/15
Limited data — score may change as more metrics become available

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

65

Safe

Based on 4 fundamental factors

+ 8 years of growth
~ Decent profit margins (15%)

Analysis Tools

Sign in for analysis tools

Share